Details for Patent: 9,549,999

✉ Email this page to a colleague

Which drugs does patent 9,549,999 protect, and when does it expire?

Patent 9,549,999 protects MYOVIEW 30ML and is included in one NDA.

This patent has eight patent family members in seven countries.

Summary for Patent: 9,549,999

Title:	Radiopharmaceutical composition
Abstract:	The present invention provides a .sup.99mTc-tetrofosmin radiopharmaceutical composition comprising tetrofosmin and a radioprotectant at a particular range of molar ratios. A kit and a multi-dose kit for the preparation of the radiopharmaceutical composition of the invention are also provided, as well as a process for the preparation of multiple unit patient doses of the radiopharmaceutical composition and a unit dose of the radiopharmaceutical composition.
Inventor(s):	Veggeland; Janne (Oslo, NO), Madsen; Grethe Karin (Oslo, NO), Hemsted; Stig (Oslo, NO)
Assignee:	GE Healthcare Limited (GB)
Application Number:	12/677,528
Patent Claim Types: see list of patent claims	Composition; Formulation; Process;

Drugs Protected by US Patent 9,549,999

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Medi-physics	MYOVIEW 30ML	technetium tc-99m tetrofosmin kit	INJECTABLE;INJECTION	020372-002	Jul 7, 2005		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,549,999

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0718386.6	Sep 21, 2007

PCT Information
PCT Filed	September 19, 2008	PCT Application Number:	PCT/EP2008/062528
PCT Publication Date:	March 26, 2009	PCT Publication Number:	WO2009/037336

International Family Members for US Patent 9,549,999

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
China	101861170	⤷ Sign Up
European Patent Office	2190484	⤷ Sign Up
Spain	2562441	⤷ Sign Up
United Kingdom	0718386	⤷ Sign Up
Hong Kong	1149203	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.